REJO Solidifies Its Global Footprint with a Prominent Presence at InterTabac 2024
REJO Unveils Innovative Heating Devices REJO AF1 and REJO Mate Air Announces Global Expansion Plans at InterTabac 2024 Signing of MOU with a major partner
REJO Unveils Innovative Heating Devices REJO AF1 and REJO Mate Air Announces Global Expansion Plans at InterTabac 2024 Signing of MOU with a major partner
VICTORIA, Seychelles, Sept. 20, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, proudly celebrates its 6th anniversary with a significant milestone
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in
Two prestigious awards presented to EBC Financial Group SINGAPORE, Sept. 19, 2024 (GLOBE NEWSWIRE) — At the BrokersView Award Ceremony in Vietnam in September 2024,
REJO Unveils Innovative Heating Devices REJO AF1 and REJO Mate Air Announces Global Expansion Plans at InterTabac 2024 Signing of MOU with a major partner
VICTORIA, Seychelles, Sept. 20, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, proudly celebrates its 6th anniversary with a significant milestone
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in
Two prestigious awards presented to EBC Financial Group SINGAPORE, Sept. 19, 2024 (GLOBE NEWSWIRE) — At the BrokersView Award Ceremony in Vietnam in September 2024,